Results
The antibacterial T6SS of Serratia marcescens displays antifungal activity. To investigate whether the bacterial T6SS could affect proliferation of eukaryotic microorganisms commonly encountered in microbial communities, the ubiquitous yeast Saccharomyces cerevisiae was used as a model target organism. Serratia marcescens Db10, which possesses a well-characterized and potent antibacterial T6SS 10 , was used as the bacterial 'attacker' . Co-culture of these two organisms resulted in > 100-fold decrease of recovered viable yeast cells, indicating that S. marcescens, itself a ubiquitous microorganism, can restrict fungal proliferation in mixed microbial cultures ( Fig. 1a ). When co-cultures were performed using S. marcescens ∆ tssE, a T6SS-inactive mutant, recovery of viable fungal cells was unaffected, demonstrating that the observed inhibition is T6SS dependent (Fig. 1a ). Direct translocation of effector proteins into a target cell requires the T6SS to puncture and traverse the target cell wall. Considering the thickness and rigidity of the fungal cell wall 11 and that the S. marcescens T6SS readily releases secreted proteins to the extracellular medium 12 , we considered that antifungal toxins might instead be secreted into the external milieu with subsequent uptake by the fungal cell. When the assay was repeated with bacterial and fungal cells separated by a cell-impermeable membrane, the number of recovered fungal cells was independent of the T6SS functionality of the underlying bacterial strain and comparable to that when placed directly on the media (Fig. 1a ). Thus bacterial-fungal cell contact is essential for antifungal T6SS activity. Next, the range of fungal target cells was expanded to include pathogenic fungi, namely Candida species, clinically important fungal pathogens commonly residing with bacteria in polymicrobial infection sites 2, 13 . We tested Candida albicans, the most frequently isolated fungal pathogen in humans, and the phylogenetically distant Candida glabrata, which displays intrinsic resistance to common antifungal drugs 14 . Both organisms were susceptible to T6SS-mediated antifungal activity, indicating a broad antifungal action of the S. marcescens T6SS (Fig. 1b ).
Identification of two antifungal T6SS effector proteins.
Having established fungi as a second target kingdom of the S. marcescens T6SS, we sought to identify the effector proteins responsible. The potential antifungal activity of six previously identified T6SS-secreted proteins (Ssp1-6 12 ) was tested by using specific effector deletion mutants as attacker strains. Deletion of SMDB11_1112 (ssp3) resulted in a four-fold increase in recovery of viable C. albicans target cells compared with the wild type, although it had little effect on S. cerevisiae or C. glabrata (Fig. 1c ). SMDB11_1112 was therefore renamed Tfe1 (T6SS antifungal effector 1). Subsequent deletion of five more effectors (mutant ∆ ssp1-6) had no additional effect on the survival of fungal cells ( Supplementary Fig. 1 ), suggesting the existence of further, unidentified T6SS-dependent effector(s).
To identify additional potential effectors, we employed a cellular proteomics approach, a complementary strategy to our previous secretome analysis, with the rationale that T6SS-secreted proteins would be retained inside the cell of a T6SS-inactive mutant. Using label-free quantitative mass spectrometry, we quantified 3,034 proteins, representing 64% of the S. marcescens Db10 genome. Twelve proteins were identified as having significantly increased intracellular abundance in the ∆ tssE mutant compared with the wild type ( Fig. 2a , Supplementary Data 1 and Supplementary Fig. 2 ). Nine were known secreted components or effectors of the T6SS machinery 12, 15 , including Tfe1, validating the approach. The remaining three proteins, of unknown function, represented candidates for previously undescribed T6SS effectors. Since, as a predicted lipoprotein, SMDB11_1031 is unlikely to be available for T6SS-dependent secretion, we focused on the two remaining candidates, SMDB11_1083 and SMDB11_3457, the latter encoded downstream of two Hcp homologues. Neither candidate is encoded adjacent to potential cognate immunity proteins (Fig. 2b) . This non-compliance with one of the main criteria for antibacterial effectors 8 further marked them as potential antifungal agents. cerevisiae K699 following co-culture with wild-type (WT) or a T6SS-inactive mutant (Δ tssE) strain of S. marcescens Db10 as attacker, or with sterile media alone, in the absence or presence of a separating membrane. b, Recovery of C. albicans SC5314 and C. glabrata ATCC2001 following co-culture with WT or a T6SS-inactive mutant of S. marcescens. c, Recovery of C. albicans (left), S. cerevisiae (middle) and C. glabrata (right) following co-culture with WT or mutant (Δ tssE, Δ tfe1, Δ tfe2, Δ tfe1Δ tfe2 and Δ SMDB11_3457) S. marcescens. d, Recovery of C. albicans, S. cerevisiae and C. glabrata following co-culture with WT or mutant strains of S. marcescens Db10 carrying either the vector control plasmid (+ VC, pSUPROM), or a plasmid directing the expression of Tfe1 with the immunity protein Sip3 (+ Tfe1) or Tfe2 (+ Tfe2). e, Immunoblot detection of Hcp1 and Ssp2 in cellular and secreted fractions of WT or mutant S. marcescens as indicated. The data are representative of two independent experiments and the full uncropped blots can be found in Supplementary Fig. 18 . In a-d, individual data points are overlaid with the mean ± s.e.m. (n = 4 biological replicates).
To determine whether SMDB11_1083 or SMDB11_3457 are T6SS-delivered antifungal toxins, the respective deletion mutants were used as attacking strains in bacterial-fungal co-cultures. Whereas loss of SMDB11_3457 did not have any effect on antifungal activity of S. marcescens, removal of SMDB11_1083 resulted in almost complete loss of activity against S. cerevisiae or C. glabrata and reduced activity against C. albicans (Fig. 1c ). SMDB11_1083 therefore represents a second T6SS-delivered antifungal effector, named Tfe2. When C. albicans was co-cultured with a mutant lacking Tfe1 and Tfe2, the partial antifungal activity seen with either single mutant was eliminated. Expression of Tfe1 and Tfe2 in trans was able to restore fungal inhibition in the respective deletion mutants (Fig. 1d ). Overexpression of Tfe1 decreased antifungal activity against S. cerevisiae and C. glabrata, perhaps indicating that competition between Tfe1 and Tfe2 for the T6SS machinery resulted in reduced delivery of the more potent Tfe2. Finally, confirming that Tfe1 and Tfe2 are not required for T6SS function, mutants lacking Tfe1 and Tfe2 had no impairment in their ability to secrete the expelled component Hcp or the effector Ssp2 ( Fig. 1e ), or in antibacterial activity against Pseudomonas fluorescens ( Supplementary Fig. 3 ).
Tfe1 can induce mild growth inhibition if overexpressed in bacterial cells, which is alleviated by co-expression with the immunity protein Sip3 12 . However, in contrast to mutants lacking immunity proteins for true antibacterial effectors 12, 15, 16 , the ∆ sip3 mutant is fully fit and is not sensitive to the T6SS of the wild type or a Tfe1overexpressing strain ( Supplementary Fig. 3 ). These data suggest that the intended target of Tfe1 is not bacterial cells, but that Sip3 acts as a failsafe against non-specific toxicity should excess Tfe1 occur. For Tfe2, no antibacterial toxicity could be detected upon overexpression, nor could a candidate immunity gene be identified. Additionally, the S. marcescens T6SS, and by implication its effectors, does not appear to act against higher eukaryotic organisms, since T6SS-inactive mutants show no loss of virulence in several models 10 ( Supplementary Fig. 4 ). Taken together, we conclude that Tfe1 and Tfe2 are the major antifungal toxins deployed by the T6SS of S. marcescens and are likely to be used only against fungal cells.
Tfe1 and Tfe2 exhibit distinct antifungal activity. Bioinformatic analysis failed to reveal conserved domains or predicted functions for Tfe1 or Tfe2. Therefore their impact on fungal cell integrity was investigated following growth in co-culture with S. marcescens. With C. albicans as the target, cell distortion and lysis was detected, dependent on the T6SS and Tfe1 in the attacking bacteria ( Fig. 3a ). In agreement with these data, many necrotic C. albicans cells were observed by cryo-TEM following co-culture with wild-type S. marcescens, whereas few such cells were seen with a T6SS-inactive mutant ( Supplementary Fig. 5 ). With S. cerevisiae or C. glabrata, granular structures were observed in a T6SS-and Tfe2-dependent manner ( Fig. 3a) , consistent with the primary role of Tfe2 against both organisms in co-culture viability assays ( Fig. 1 ). Propidium iodide (PI) stains cells that have lost the membrane permeability barrier, a common indirect proxy for loss of viability. We observed that ~50% of C. albicans and C. glabrata cells recovered from cocultures with S. marcescens showed PI staining, dependent on the T6SS and either Tfe1 (C. albicans) or Tfe2 (C. glabrata) (Fig. 3b ). These observations are consistent with co-culture viable count assays ( Fig. 1) , where recovery of viable fungal cells co-cultured with wild-type S. marcescens was lower than the initial inoculum, implying fungicidal action. In contrast, PI staining was not observed in S. cerevisiae. To confirm directly that Tfe1 and Tfe2 possess intrinsic antifungal activity, and investigate further their impact on the different fungal species, each effector was expressed in S. cerevisiae and 
Fig. 2 |
Quantitative cellular proteomics identifies known and previously unidentified T6SS-secreted proteins. a, Volcano plot summarizing the proteomic comparison of total intracellular proteins between the WT and a T6SS-inactive mutant (Δ tssE) strain of S. marcescens Db10 using label-free quantification. The log 2 of the ratios of protein intensities between the WT and the Δ tssE mutant are plotted against the -log 10 of t-test P values (twosided unpaired t-test; n = 6 biological replicates). Proteins significantly increased in abundance in the Δ tssE mutant compared with the WT (Δ tssE/ WT > 1.4-fold, P < 0.05) are depicted as circles, with magenta circles representing those secreted effectors (SE) identified as antifungal effectors in this study, and blue circles representing other hits, including secreted core components (SCC) or previously identified secreted effectors. Grey squares represent proteins significantly decreased in abundance in the Δ tssE mutant compared with the WT (Δ tssE/WT < − 1.4-fold, P < 0.05) and black diamonds correspond to proteins without significant changes. Numbers in brackets represent genomic identifiers for the proteins (SMDB11_xxxx). b, Schematic depiction of the genetic loci containing the tfe1, tfe2 and SMDB11_3457 genes in S. marcescens Db10. The sip3 gene encodes the previously identified immunity protein for Tfe1/Ssp3. C. albicans using galactose-and doxycycline-inducible 17 expression systems, respectively. Expression of Tfe1, but not the antibacterial effectors Ssp1 and Ssp2, strongly inhibited growth of S. cerevisiae and induced abnormally large vacuoles and cell lysis ( Fig. 3d ,e and Supplementary Fig. 6 ), confirming the fungicidal potential of Tfe1. Similarly, expression of Tfe1 in C. albicans caused growth inhibition and cell death ( Supplementary Fig. 7 ) and reproduced the Tfe1dependent morphological changes observed in co-culture ( Fig. 3c ). Expression of Tfe2 in S. cerevisiae, while not causing obvious changes in morphology, was able to abolish growth, even at very low levels ( Fig. 3c,d ).
Induction of Tfe2 during logarithmic growth of S. cerevisiae in liquid cultures resulted in a decline in the number of viable cells over time, whereas cell density approached a steady state. Following removal of induction, yeast cells recovered from Tfe2-induced growth inhibition within 3 h to resume normal growth ( Fig. 4a ).
These results indicate that Tfe2-mediated intoxication of S. cerevisiae primarily results in growth inhibition, with reduced long-term survival as a downstream consequence. To investigate whether the fungistatic effect of Tfe2 on S. cerevisiae was caused by inhibition of metabolic activity, the fluorescent dye FUN1 was used. Metabolically active cells transport the dye into the vacuole, where it forms distinct tubular structures which exhibit red fluorescence. In metabolically inactive cells, the dye remains in the cytoplasm and fluoresces green 18 . Bright red structures, apparently vacuoleassociated and similar to those observed in the control strain, were detected during early stages of Tfe1 expression when the cells increased dramatically in size ( Fig. 4b ), eventually being replaced by green fluorescence before onset of lysis. Tfe2-expressing cells also displayed bright red fluorescent structures, but these appeared more globular, dispersed and mainly outside the vacuole. Together with the persistence of green fluorescence, this indicates that Tfe2 causes reduced cellular metabolic activity and potential interference with vacuolar transport 19 .
To determine whether either effector causes loss of plasma membrane potential, S. cerevisiae cells expressing Tfe1 or Tfe2 were stained with the voltage-dependent dye DiBAC 4 (3), which enters cells in a depolarization-dependent manner. Tfe1 intoxication resulted in membrane depolarization, similar to treatment with mellitin and amphotericin B, whereas Tfe2 caused no loss of membrane potential ( Fig. 4c ). Co-staining with PI revealed that only a fraction of the Tfe1-intoxicated cells showing depolarization also exhibited a loss of membrane integrity, in contrast with the action of the pore-forming peptide mellitin where all depolarized cells were also permeabilized ( Fig. 4d and Supplementary Fig. 8 ). Intoxication of C. albicans by T6SS-delivered Tfe1 caused a similar pattern of membrane depolarization and selective permeability ( Supplementary Fig. 9 ). Thus our data suggest that Tfe1 primarily causes a loss of membrane potential, which is not due to pore formation but can ultimately lead to a loss of membrane integrity, and imply that Tfe1 and Tfe2 act on different cellular targets in fungal cells. The T6SS can act on filamentous fungal cells. While P. aeruginosa has been reported to preferentially kill the hyphal form of C. albicans 20 , we had so far demonstrated T6SS activity against only the budding yeast form. Co-culture of S. marcescens with the constitutively filamentous Δ tup1 mutant 21 revealed PI staining of individual cell segments within filaments, with this localized action being dependent on the T6SS and Tfe1 (Fig. 4e,f) . A T6SSand Tfe1-dependent drop in viable cell counts was also observed ( Supplementary Fig. 10 ). Thus the antifungal S. marcescens T6SS can intoxicate both budding and filamentous forms of C. albicans.
In competition proteomics reveals that T6SS-delivered Tfe2 disrupts nutrient transport and metabolism and induces autophagy.
To identify specific cellular pathways affected by the antifungal effectors in a physiologically relevant context, namely when delivered by the T6SS, we performed in competition proteomics using C. albicans as the target. Fungal cells were co-cultured with wildtype S. marcescens Db10, the T6SS-inactive mutant ∆ tssE, or effector mutants, ∆ tfe1, ∆ tfe2 and ∆ tfe1∆ tfe2, before performing quantitative mass spectrometric analysis of the total fungal proteome in each condition using isotope-labelled tandem mass tags (six-plex TMT). 4,446 C. albicans proteins (~72% of the genome) and 2,486 S. marcescens proteins were quantified (Supplementary Data 2 and Supplementary Figs. [11] [12] [13] [14] [15] . Of the C. albicans proteins, 1,667 showed significant modulation across the five-way comparison (ANOVA-positive, P < 0.05). Hierarchical clustering of these modulated proteins confirmed that Tfe1 and Tfe2 cause disruption of different fungal pathways. The analysis also demonstrated that the major response of C. albicans is to T6SS-dependent translocation of Tfe2, since the response to the ∆ tfe2 mutant was similar to that of ∆ tssE or ∆ tfe1∆ tfe2 (Fig. 5a ). To identify individual proteins within this set as being robustly altered in specific response to Tfe2, we further imposed requirements for a significant change in abundance (> 1.3-fold) to be observed in the presence of the wild type compared with the ∆ tfe2 mutant, and for a consistent change to be observed in ∆ tfe1∆ tfe2 and ∆ tssE mutants. According to these criteria, 14 fungal proteins were upregulated in response to Tfe2 delivery and 16 downregulated ( Supplementary Table 1 ). In contrast, no Tfe1-specific proteins were identified using these strict criteria. This may, at least in part, reflect Tfe1 acting on a non-protein target, consistent with its ability to induce plasma membrane depolarization. Evaluation of the 30 Tfe2-responsive proteins by Gene Ontology enrichment analysis identified significant overrepresentation of proteins belonging to the cellular amino acid biosynthetic process (GOID 8652), specifically arginine biosynthesis (GOID 6526) and sulfur amino acid biosynthesis (GOID 0097), as well as anion transport (GOID 6820) ( Fig. 5b and Supplementary Table 2 ). Subsequent analysis was therefore focused on these areas of nutrient uptake and amino acid metabolism. Fungal cells must acquire sulfur from their environment for the de novo biosynthesis of cysteine, methionine and other organic sulfur metabolites, such as glutathione 22 . The sole sulfate transporter in C. albicans, Sul2, and members of the sulfate assimilation pathway were strongly decreased in the presence of Tfe2-translocating bacteria. Heat map analysis of relevant proteins revealed downregulation of the entire pathway for reduction of inorganic sulfate to homocysteine in response to Tfe2 (Fig. 5c ). Similar to Sul2, two general amino acid permeases, Gap1 and Gap2, and two basic amino acid permeases, Can1 and Can2 (all of which transport arginine into the fungal cell [23] [24] [25] , were subject to Tfe2-dependent downregulation (Fig. 5d ). Furthermore, examination of arginine metabolic proteins 26 in the proteomics dataset indicated Tfe2-dependent accumulation of proteins involved in arginine synthesis, whereas proteins mediating arginine catabolism were unchanged or decreased ( Fig. 5d ). Consistent with this profile, intracellular arginine levels in S. cerevisiae expressing Tfe2 were increased four-fold compared with control cells (Fig. 6a ). Lysine levels were also increased, and a further 14 amino acids displayed a range of down-or upregulation, indicating extensive nutrient imbalance following Tfe2-mediated intoxication.
Next, we determined if Tfe2-induced reduction of fungal nutrient transporters, which also included the peptide transporter Ptr22
( Supplementary Table 1 ), is due to transcriptional downregulation. Plasma membrane transporter expression is induced by substrate, which is sensed by the transporter itself, as for Sul2, or by nontransporting membrane proteins, including the amino acid sensor Csy1 (Ssy1 in S. cerevisiae), a component of the SPS sensing complex 27, 28 . Transcript levels of the sensor gene SSY1, SPS-activated transcriptional regulators STP1 and STP2 and SPS-controlled permease genes [29] [30] [31] were increased following expression of Tfe2 in S. cerevisiae (Fig. 6b ). This implies that Tfe2 does not inhibit SPS sensing or signalling. Rather, transcriptional induction of the SPS regulon is consistent with Tfe2-induced intracellular nutrient depletion or imbalance. Similarly, sulfate transporter transcript levels were upregulated by Tfe2, despite downregulation at the protein level. We confirmed that T6SS-mediated delivery of Tfe2 decreases levels of Can1 in S. cerevisiae, with redistribution from the plasma membrane suggesting vacuolar degradation ( Supplementary Fig. 16 ). These data indicate that Tfe2 intoxication causes depletion of nutrient transporters at a post-transcriptional level. In turn, the resulting decrease in intracellular nutrients may lead to downregulation of nutrient-utilization pathways, as observed for proteins of the sulfate assimilation pathway ( Fig. 5c ), or in upregulation of compensatory metabolic pathways, as observed for arginine synthesis (Fig. 5d ).
Further evidence for Tfe2-dependent interference with the intracellular amino acid pool was the marked increase in the bZip transcriptional activator protein Gcn4 ( Supplementary Table 1 ), which mediates the general amino acid control (GAAC) response to amino acid starvation 32, 33 . The proteomics data also revealed a Tfe2-dependent increase in the levels of Atg1, a Ser/Thr kinase subject to regulation by the nutrient-sensing TOR signalling pathway. Activation of Atg1 by phosphorylation in response to nitrogen and amino acid starvation leads to induction of autophagy 34 . To investigate if Tfe2-mediated amino acid limitation leads to autophagy, we analysed proteolytic processing of the autophagy reporter protein GFP-Atg8 35, 36 in S. cerevisiae co-cultured with S. marcescens. With yeast alone, only full-length GFP-Atg8 was observed. When co-cultured with wild-type S. marcescens, a band corresponding to free GFP was detected, indicating processing of GFP-Atg8 by vacuolar peptidases and thus induction of autophagy. Processing was not detected when co-cultured with bacteria lacking Tfe2 or a functional T6SS, nor in cells lacking the key autophagy regulator, Atg13 ( Fig. 6c , Supplementary Fig. 17 ). Hence induction of autophagy is dependent on T6SS-mediated delivery of Tfe2. Although Tfe2 may induce autophagy independent of amino acid imbalance, our results are consistent with the idea that Tfe2-mediated intoxication of fungal cells leads to disruption of the intracellular amino acid pool, causing a starvation signal which induces autophagy as a protective response.
Overall, we have revealed that Tfe2 intoxication leads to extensive nutrient imbalance, interference with plasma membrane transporters and induction of autophagy. The precise aspect or combination of these factors that ultimately leads to the death of the fungal cell remains to be deciphered. In contrast, Tfe1 acts via a plasma membrane depolarizing mechanism that does not involve formation of large, unselective pores.
Discussion
Cellular proteomics combined with genetic analysis led us to discover the first T6SS-dependent antifungal effectors, Tfe1 and Tfe2, whose T6SS-dependent secretion was confirmed in our concurrent secretome study 15 . The two effectors elicit distinct responses in fungal cells and can exert a fungicidal effect. The severity of the fungal response to each toxin differs between species, which is likely to reflect divergence of metabolic pathways. In competition proteomics revealed that T6SS-delivered Tfe2 disrupts fungal nutrient uptake and metabolism. In particular, Tfe2 intoxication strongly affected inter-related pathways involved in sulfate assimilation, plasma membrane nutrient transport and amino acid metabolism and also caused induction of autophagy. Autophagy is a process by which, under nutrient-limiting stress conditions, fungal cells target cellular macromolecules for vacuolar degradation and recycling 34, 37 . Induction of this pathway in response to Tfe2 indicates severe disturbance of the intracellular metabolic equilibrium and may represent a protective response attempting to rescue the viability of the fungal cell. A striking change in response to Tfe2 was increased intracellular levels of arginine and lysine. Upregulation of arginine and lysine synthesis has been linked to sudden nutrient limitation 
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Arg8 Ecm42 Arginine Table 1 ). Where different, the protein name in S. cerevisiae is given in brackets. c,d, Schematic illustration (left) and corresponding heat maps of the pathway-associated proteins (right) of the sulfate assimilation and arginine biosynthesis pathways in fungal cells. Proteins that increased in abundance following co-culture with WT S. marcescens compared with the indicated mutant strains are shown in purple, and proteins that decreased in abundance are shown in orange. Cyto., cytoplasm; Mito., mitochondria.
after engulfment by neutrophils 38, 39 , and regulation of arginine synthesis in response to phagocytosis may also represent a protective mechanism against the phagocyte oxidative burst in C. albicans 40, 41 .
Thus Tfe2 may be causing a similar response to that induced following phagocytosis. Tfe1, in contrast, does not provoke a strong proteomic response and instead causes plasma membrane depolarization, reminiscent of T6SS-delivered antibacterial effectors that target the bacterial membrane 8 . This study demonstrates that the bacterial T6SS can act as a potent antifungal weapon, causing growth arrest and death of fungal cells. In agreement with the prevailing model, T6SS-dependent antifungal activity required attacker-target cell-cell contact, suggesting that effector translocation occurs directly into the fungal cell. Supporting the feasibility of this idea, cryo-TEM showed an intimate interaction between cells of C. albicans and S. marcescens ( Supplementary Fig. 5 ). Moreover, the expelled arrow-like structure of the T6SS should have both the length (approximately 0.7 µ m, at least three times the thickness of the average fungal cell wall) [42] [43] [44] and the force 4 to puncture the rigid fungal cell wall. The S. marcescens T6SS delivers multiple antibacterial effectors and is a potent weapon against competitor bacteria 10 . However, this study reveals a second, prominent role for this T6SS in controlling growth of co-habiting fungal microorganisms. While Serratia-Candida interactions may on occasion be relevant clinically, given that both can colonize common sites such as the bloodstream, respiratory system and GI tract 2, 45, 46 , Serratia is ubiquitous in the environment and is likely to use its antifungal T6SS in diverse contexts. More importantly, our work implies that other bacterial pathogens may deploy a T6SS against fungal cells during polymicrobial infection. This is supported by the observation that Tfe2 homologues are present in other pathogenic T6SS-containing bacteria, including Pseudomonas and Vibrio species. Thus, we propose that antifungal T6SS activity is widespread and may be an intrinsic property of many, if not all, 'antibacterial' T6SSs. Indeed, one report has suggested anti-yeast activity associated with a T6SS in P. syringae, although no effectors were identified 47 . The fact that T6SS antifungal effectors have not been discovered previously may be partially attributable to many identification strategies relying on the presence of associated immunity proteins, therefore excluding proteins such as Tfe2.
With the identification of a previously undescribed class of effectors, antifungal toxins, we have expanded the repertoire of the T6SS arsenal to include another target kingdom and highlighted another role for this versatile machinery in shaping polymicrobial communities. Deployment of T6SSs enabling simultaneous attack on prokaryotic and fungal rivals should represent a key determinant of bacterial competitive fitness in a multitude of environments, from rhizosphere to polymicrobial human infections.
Methods
Bacterial strains, plasmids and culture conditions. Bacterial strains and plasmids used in this study are given in Supplementary Table 3 . Mutant strains of S. marcescens Db10 carrying in-frame deletions were generated by allelic exchange using the pKNG101 suicide vector, and effector genes were cloned into pSUPROM for constitutive expression in trans 10 . To avoid non-specific antibacterial toxicity after complementation of the Δ tfe1 strain by plasmid-encoded Tfe1, the cognate immunity gene sip3 was included in the construct. All primer sequences for mutant and plasmid generation are given in Supplementary Table 4 . Strains of S. marcescens were grown at 30 °C in LB media (10 g l −1 tryptone, 5 g l −1 yeast extract, 10 g l −1 NaCl), solidified with 12 g l −1 agar or supplemented with antibiotics (kanamycin, 100 μ g ml −1 ; streptomycin, 100 μ g ml −1 ) where required.
Fungal strains, plasmids and culture conditions. Fungal strains and plasmids are given in Supplementary Table 3 . To generate mutant strains of S. cerevisiae K699 carrying chromosomal insertions of GFP or bacterial effector genes under the control of the P GAL1 promoter, linearized plasmids pSC1384 (control), pSC1379 (GFP), pSC1382 (Tfe1) and pSC1380 (Tfe2), all based on plasmid pGED1, were integrated by allelic exchange into the HIS3 locus. Plasmid-based gene expression used the galactose-inducible vector pRB1438. For in trans expression of bacterial effectors in C. albicans, chromosomal integration mutants based on the doxycycline-inducible expression vector pNIM1 17 were generated. To ensure correct leucine incorporation into the expressed protein in C. albicans, synthetic genes carrying CTG to TTG substitutions (Invitrogen) were subcloned into pNIM1. Correct sequence and locus integration was confirmed by sequencing of GFP-Atg8 has a molecular weight of 41 kDa and cleaved GFP is 27 kDa. Pgk1 was used as control cellular protein and dashed line indicates where the blot membrane was cut to allow detection with the two different antibodies; the full uncropped blots can be found in Supplementary Fig. 18 . These data are representative of three independent experiments.
the respective PCR product, together with Southern blot analysis for C. albicans. All primer sequences for mutant and plasmid generation and Southern blot probe generation are given in Supplementary Table 4 . Fungal strains were cultured at 30 °C in YPDA (10 g l −1 yeast extract, 20 g l −1 peptone, 40 mg l −1 adenine hemisulfate) or synthetic complete (SC; 6.9 g l −1 yeast nitrogen base complete with ammonium sulfate and amino acids) media containing 2% glucose 48 . If using auxotrophies, SC media lacking the respective amino acid or nucleotide was used. For induction of the P GAL1 promoter, S. cerevisiae cultures were pre-incubated in media containing 2% raffinose, washed and incubated with media containing both 2% galactose and 2% raffinose unless otherwise stated. Induction of the Tet-inducible promoter in C. albicans was by addition of 50 µ g ml −1 doxycycline.
Co-culture assay for T6SS-mediated antifungal activity. Antifungal activity assays were based on the antibacterial co-culture assay described previously 10 . Both the attacker strain derived from S. marcescens Db10 and the respective fungal target strain were normalized to an OD 600 of 1, mixed at a volume ratio of 1:1 (attacker:target cell ratio ~100:1), and 12.5 µ l of the mixture were spotted on solid SC + 2% glucose media and incubated for 7.5 h at 30 °C. Surviving target fungal cells were enumerated by serial dilution and viable counts on streptomycinsupplemented YPDA media. Co-culture assays for antibacterial activity were performed as described 10, 16 . For assessment of cell contact dependence, bacterial and fungal cells were separated by a membrane (pore size 0.22 µ m), with the bacterial layer between the solid medium and the membrane and the fungal cells spotted on top of the membrane. S. cerevisiae grew equally well on the membrane placed on top of the bacterial cell layer compared with direct growth on the medium, confirming efficient diffusion of nutrients through the membrane. The co-culture experiments presented contain data from four independent biological replicates, performed on at least two days, with T6SS-dependent antifungal activity and the phenotypes of the Δ tfe1 and Δ tfe2 mutants having been confirmed on multiple independent occasions.
Plate toxicity assay. Fungal cells were pre-grown in non-inducing liquid minimal media (SC + 2% glucose, C. albicans; DOA-LEU + 2% raffinose, S. cerevisiae) at 30 °C, adjusted to an OD 600 of 1, serially diluted and 5 µ l spotted onto minimal media agar. Heterologous protein expression was induced by addition of doxycyline (50 µ g ml −1 , C. albicans) or galactose (0.008-0.2%, S. cerevisiae). Agar plates were incubated at 30 °C and pictures taken after 48 h (C. albicans) or 96 h (S. cerevisiae).
Cell morphology and viability analysis by microscopy.
Single cell morphology of fungal cells grown in co-culture (7.5 h) or in liquid induction media (SC + 2% glucose + 50 µ g ml −1 doxycycline, C. albicans; DOA-URA + 2% raffinose + 2% galactose, S. cerevisiae; 8 h) was visualized by DIC using a Axio-Imager M1 microscope equipped with a 100× objective, AxioCam MRm camera and ZEN software (Zeiss). The images presented show multiple individual cells from part of one field of view, for clarity, and are representative of between 9 and 42 fields of view, acquired on three separate occasions. To determine the percentage of PI-stained fungal cells, cells from three independent fungal-bacterial co-cultures grown at 30 °C for 7.5 h on solid SC + 2% glucose media were recovered in 1× PBS and stained with PI at a final concentration of 10 µ g ml −1 . Following a 15 min incubation at 30 °C, 1.5 μ l of the stained cell suspension were placed on a microscope slide layered with a 1% agarose pad and cells were detected by both DIC and fluorescence microscopy using a HBO 100 mercury lamp and appropriate filter sets (excitation 546/12 nm, emission 607/65 nm) and 40× objective. A minimum of 160 cells per experimental condition and replicate were scored, with the aid of the counting tool in OMERO.mtools 49 . Cells subjected to a 40 min heat-shock at 65 °C served as positive control for PI staining. Visualization of C. albicans hyphae was performed using a Zeiss Axioskop 2 MOT microscope, 63× objective, HBO100 mercury lamp and Zeiss Axiocam Color camera, following incubation with 1 µ M PI for 10 min. Microscopy images were managed and processed according to accepted standards using OMERO (http://openmicroscopy.org) 49 and Fiji 50 .
Microscopy analysis of metabolic activity and membrane potential.
For staining of effector-expressing S. cerevisiae cells using FUN1, cells were grown in synthetic drop-out media (DOA-LEU) supplemented with 2% raffinose, washed once, normalized to an OD 600 of 0.5 and expression induced by addition of 2% galactose for 9 h. Cells were washed, suspended in 10 mM HEPES, pH 7.2, 2% raffinose, 2% galactose, stained with FUN1 (Thermo-Fisher, dilution 1:1;000) for 30 min at 30 °C, and analysed by DIC and fluorescence microscopy using appropriate filter sets (green, excitation 470/40 nm, emission 525/50 nm, 40 ms exposure; and red, excitation 546/12 nm, emission 607/65 nm, 150 ms exposure) on the Axio-Imager described above. Multiple fields of view were imaged and the experiment has been reproduced on an independent occasion. To visualize and distinguish between changes in plasma membrane potential and membrane diffusion barrier function, S. cerevisiae cells grown in liquid induction media (DOA-URA + 2% raffinose + 2% galactose; 6 h) were placed on a microscope slide layered with a 1% agarose pad containing the voltage-dependent dye Bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC 4 (3)) (AnaSpec) at a final concentration of 10 µ M, either alone, or combined with the membrane permeability reporter PI (Sigma) added at a final concentration of 1 µ M. To suppress binding of DiBAC 4 (3) on the glass surface, the coverslips were coated with L-dopamine 51 . Amphotericin B (Sigma), used as positive control to induce membrane depolarization without pore formation, was added to control cells at the start of the 6 h induction period at a final concentration of 3 µ g ml −1 . The poreforming peptide mellitin (AnaSpec) was added to the cells 10 min before the end of the 6 h induction period at a final concentration of 10 µ M. Fluorescence and phase contrast microscopy was carried out with Nikon Eclipse Ti equipped with Nikon Plan Apo 100× /1.40 NA Oil Ph3 objective, Sutter Instrument Company Lambda LS xenon arc light source, and Photometrics Prime sCMOS camera using appropriate filter sets (green excitation 470/40 nm, emission 525/50 nm, 500 ms exposure; and red excitation 560/40 nm, emission 630/40 nm, 100 ms exposure). The images were captured using Metamorph 7.7 (Molecular Devices). Multiple fields of view were imaged and the experiment has been reproduced on an independent occasion. The quantification of cell fluorescence levels was performed by automated detection of cells using phase contrast images, followed by measurement of whole-cell DiBAC 4 (3) and PI average fluorescence intensities from corresponding, background-subtracted fluorescent micrographs. The cell detection and fluorescence intensity measurements were carried out using Fiji 50 .
Microscopy analysis of Can1-GFP localization in S. cerevisiae.
To determine cellular localization of fungal Can1-GFP when co-cultured with Serratia, yeastbacterial co-cultures were resuspended into SC media, incubated for 10 min at 30 °C with the fluorescent dye CellTracker Blue CMAC (Thermo-Fisher) at a final concentration of 100 µ M, washed once and mounted on 1% agarose pads. The fluorescent and phase contrast images were captured with Nikon Eclipse Ti equipped with Nikon Plan Apo 100× /1.40 NA Oil Ph3 objective, Sutter Instrument Company Lambda LS xenon arc light source, and Photometrics Prime sCMOS camera using appropriate filter sets (blue excitation 350/50 nm, emission 460/50 nm, 1 s exposure; green excitation 470/40 nm, emission 525/50 nm, 1 s exposure). The images were captured using Metamorph 7.7 (Molecular Devices). Multiple fields of view were imaged and the experiment has been reproduced on an independent occasion. The quantification of the Can1-GFP fluorescence emitted from the plasma membrane under the different experimental conditions was carried out by randomly selecting 30 individual cells based on phase contrast images, followed by measurement of plasma membrane and cell interior fluorescence signals from the corresponding, background-subtracted fluorescent micrographs. The plasma membrane signal was measured as the average signal intensity of the cell area corresponding to a manually drawn 6-pixel wide line tracing the cell edge. The interior fluorescent signal was measured as the average signal intensity of the whole cell area, as determined by manually tracing and excluding the cell periphery. The determination of the measurement areas, and the quantification of the corresponding average fluorescence levels were carried out with Fiji 50 .
Cryo-transmission electron microscopy. S. marcescens and C. albicans were co-cultured as above. High-pressure freezing was carried out using a Leica EM PACT 2 (Leica Microsystems, Milton Keynes, UK) and samples were freeze substituted in a Leica AFS 2. Freeze substitution was carried out using the following program: − 95 °C to − 90 °C for 30 h with 2% OsO 4 in acetone, − 90 °C for 10 h with 2% OsO 4 in acetone, − 90 °C to − 30 °C for 8 h with 2% OsO 4 in acetone, − 30 °C to − 10 °C for 1 h with acetone, − 10 °C to 4 °C for 1 h in acetone, 4 °C to 20 °C for 1 h in acetone. Samples were then placed in 10% Spurr's (TAAB, UK): acetone for 72 h, followed by 30% Spurr's overnight, 50% Spurr's for 8 h, 70% Spurr's overnight, 90% Spurr's for 8 h and embedded in Spurr's resin at 60 °C for at least 24 h. Ultrathin sections were cut to 90 µ m using a diamond knife (Diatome Ltd, Switzerland) onto copper grids (TAAB, UK) using a Leica UC6 and were contrast stained with uranyl acetate and lead citrate in a Leica AC20. Samples were imaged on a JEM 1400 plus (JEOL UK) Transmission Electron Microscope and captured using an AMT UltraVUE camera (AMT, USA).
Immunoblot analysis.
Anti-Hcp and anti-Ssp2 immunoblots were performed on cultures grown for 5 h as previously described 10, 16 . Polyclonal anti-Hcp 10 and anti-Ssp2 16 primary antibodies were used at 1:6,000 and 1:2,000 respectively, with peroxidase-conjugated anti-rabbit secondary antibody (BioRad) at 1:10,000. Cellular samples for immunodetection of GFP-Atg8 and corresponding Pgk1 control were prepared from yeast-bacterial co-cultures based on 52 . Yeast cells were harvested from co-cultures grown at 30 °C for 7.5 h on solid DOA-URA media into ice-cold phosphate buffered saline (PBS; 8 g l −1 NaCl, 0.2 g l −1 KCl, 1.42 g l −1 Na 2 HPO 4 , 0.24 g l −1 KH 2 PO 4 , pH 7.4), washed twice by filtering through 3 µ m pore-sized PVDF membranes (Millipore) and recovered by centrifugation. For subsequent protein extraction, cell pellets were resuspended and incubated for 10 min in 0.2 M NaOH, 1% β -mercaptoethanol. Proteins were precipitated by addition of trichloroacetic acid (TCA; 20% final concentration), washed once in ice-cold acetone, resuspended in 2× SDS sample buffer (100 mM Tris-HCl, pH 6.8, 3.2% SDS, 3.2 mM EDTA, 16% glycerol, 0.2 mg ml −1 bromophenol blue and 2.5% β -mercaptoethanol) and boiled for 10 min. Cellular samples for immunodetection of Can1-GFP and corresponding Pgk1 control were prepared from yeast-bacterial co-cultures based on 53 . Yeast cells were harvested from co-cultures grown at 30 °C for 7.5 h on solid SC + 2% glucose media into ice-cold PBS, washed twice by filtering through 3 µ m pore-sized PVDF membranes and recovered by centrifugation. For subsequent protein extraction, cell pellets were resuspended in 10% ice-cold TCA, washed twice in acetone and resuspended in MURB-based buffer (25 mM MOPS, 50 mM phosphate buffer, pH 7.0, 3 M urea, 1 % SDS, bromophenol blue, 1 mM NaN 3 , 0.5% β -mercaptoethanol). This was followed by disruption with approximately one-half volume of acid-washed glass beads using a Mini-BeadBeater-16 (BioSpec Products) (5 × 30 s with 30-s intervals). Samples were separated by SDS-PAGE and subjected to immunoblotting. For GFP-ATG8 and Can1-GFP experiments, due to the growth impediment of S. cerevisiae in the presence of S. marcescens Db10 and residual bacterial contamination of yeast samples, protein extracts were normalized according to the abundance of the protein Pgk1. Monoclonal anti-GFP (cat. no. 11814460001, Roche) and polyclonal anti-Pgk1 (cat. no. 13472727, Invitrogen) primary antibodies were used at 1:5,000 and 1:1,000 respectively, with peroxidase-conjugated anti-mouse and anti-rabbit secondary antibodies (BioRad) at 1:10,000. Visualization utilized conventional ECL and X-ray film, except in the case of Can1-GFP where the same membrane was then reprobed with anti-Pgk1 and visualized using a Typhoon imaging system (GE Healthcare).
Quantitative real-time PCR. RNA was extracted from three independent cultures of control and Tfe2-expressing S. cerevisiae cells, induced for 6 h at 30 °C in galactose induction media, using the SV Total RNA Isolation System (Promega), followed by treatment with the Turbo DNA-free kit (Ambion) to remove residual gDNA. RNA was reverse transcribed using the iScript cDNA Synthesis Kit (BioRad) and relative levels of cDNA determined using an Mx3005P QPCR machine (Stratagene, Agilent Technologies) with actin (ACT1) as the normalizing gene. Primer sequences are given in Supplementary Table 4 . The experiment presented has been reproduced on an independent occasion.
Whole-cell amino acid analysis. Three independent cultures of control and
Tfe2-expressing S. cerevisiae cells were incubated for 6 h at 30 °C in galactose induction media, washed twice with ice-cold water, normalized to 5 OD 600 per 1 ml of water and boiled for 15 min. After centrifugation, the supernatant was clarified using a 0.2 µ m syringe filter (Sartorius). The resulting extract was acidified by addition of TFA in MeOH (10%, v/v), dried and resuspended in buffer (40% 1 M NaOAc, 40% MeOH, 20% triethylamine, TEA), before being dried again. The amino acids were then derivatized using Phenylisothiocyanate (PITC) by resuspension of the dried material in 10% PITC, 70% MeOH, 10% H 2 O, 10% TEA, followed by two-fold dilution in MeOH. After 15 min incubation at room temperature, suspensions were dried, washed once with MeOH and suspended in elution buffer, composed of 95% (150 mM NaOAc, 0.5 ml l −1 TEA, pH 6.4) and 5% acetonitrile. PTC amino acid derivatives were analysed by HPLC using a Nova-Pak C18 column (Waters), the Clarity Lite software and two amino acid standard sets (AA-S-18 and A6282, Sigma). The experiment presented has been reproduced on two independent occasions.
Infection of RAW264.7 cells with S. marcescens.
Murine macrophage-like cells RAW264.7 were cultured in Dulbecco's Modified Eagle's medium GlutaMax (Invitrogen) supplemented with 10% foetal bovine serum (Sigma) and grown at 37 °C, 5% CO 2 . RAW264.7 cells were cultured in 24-well plates at a density of 200,000 cells per well for 24 h before the infection assay. RAW264.7 cells were infected with strains of S. marcescens at a multiplicity of infection of 10 for 2 h, 4 h and 6 h. The morphology of RAW264.7 cells was monitored during the course of infection and culture supernatants were collected at each time point for the cytotoxicity assay. Within each independent experiment, an infection with each bacterial strain was performed in duplicate cell culture wells (technical replicate). To measure cytotoxicity, culture supernatants, cleared by centrifugation at 18,000g for 2 min, were analysed for the presence of lactate dehydrogenase (LDH) using the Pierce LDH cytotoxicity assay kit (Thermo-Fisher). Cytotoxicity (%) was determined by the quantification of LDH release in the culture supernatant relative to total cellular LDH release from complete cell lysis with 0.1% Triton X-100 (100%). Derivatives of S. marcescens Db10 and SJC11(Δ tssE) lacking production of secreted haemolysin were generated by introduction of the shlB::miniTn5-Cm insertion from strain 21C4 54 by generalized transduction using Φ IF3 55 . RAW264.7 cells were obtained from ATCC. The stock has been authenticated previously by proteomics and has been tested regularly for mycoplasma contamination.
Sample preparation for mass spectrometry. For analysis of the cellular proteome of S. marcescens, six biological replicates of each strain (two spots of 25 µ l of OD 600 0.5 per replicate) were grown on solid LB media for 7.5 h at 30 °C. Cells were recovered, washed in ice-cold PBS, resuspended in 1% sodium 3-[(2-methyl-2-undecyl-1,3-dioxolan-4-yl)methoxy]-1-propanesulfonate (commercially available as RapiGest, Waters, Milford, MA), 50 mM Tris-HCl pH 8.0, 1 mM tris(2-carboxyethyl)phosphine (TCEP) and lysed by sonication.
For analysis of bacterially-intoxicated fungal cells, co-cultures of C. albicans and S. marcescens (57 co-culture spots, inoculated as above, per replicate) were incubated on solid SC + 2% glucose media for 4 h at 30 °C, with six biological replicates per combination. Cells were harvested in 40 ml ice-cold PBS, washed twice by filtration using PVDF membranes, pore size 3 µ m (Millipore), suspended in PBS and recovered by centrifugation. Cells were sonicated in 1% Rapigest, 50 mM Tris-HCl pH 8.0, 1 mM TCEP in the presence of 0.1 mm zirconia/silica beads (BioSpec) for 6 × 10 s with 20 s intervals. In each study, following sonication, samples were heated for 5 min at 95 °C and soluble protein extracts recovered by centrifugation.
Protein concentrations were determined using the EZQ Kit (Thermo-Fisher Scientific) and cysteines were alkylated by addition of 5 mM iodoacetamide. After 20 min incubation in the dark at 25 °C, the reaction was quenched by addition of 5 mM DTT and samples were diluted 10 × in 50 mM Tris-HCl pH 8.0. Digestion of proteins was by addition of trypsin (MS grade, Pierce, Thermo-Fisher) at a 1:150 (w/w) ratio with incubation overnight at 37 °C, followed by a second addition of trypsin (1:150 w/w) with 3 h incubation. Rapigest was cleaved by addition of 2% trifluoroacetic acid (TFA) and incubation for 1 h at 37 °C. Samples were desalted using C18 columns (Harvard Apparatus) and lyophilized.
Mass spectrometry analysis of S. marcescens cellular proteome. Lyophilized peptide samples (six biological replicates) were taken up in 2% acetonitrile (ACN), 0.1% TFA and analysed similar to previously published methods [56] [57] [58] : separated on an Ultimate 3000 RSLC system (Thermo-Fisher Scientific) with a C18 PepMap, serving as a trapping column (2 cm × 100 µ m ID, PepMap C18, 5 µ m particles, 100 Å pore size) followed by a 50 cm EASY-Spray column (50 cm × 75 µ m ID, PepMap C18, 2 µ m particles, 100 Å pore size; Thermo-Fisher Scientific) with a 6 h gradient consisting of 3-30% B (B = 80% ACN, 0.1% formic acid (FA); 10-260 min), to 40% B (330 min), 99% B (335-345 min), 3% (350-360 min) at 300 nl/min. Mass spectrometric identification and quantification was performed on an Orbitrap Velos mass spectrometer (Thermo-Fisher Scientific) operated in data dependent, positive ion mode. FullScan spectra were acquired in a range from 350 m/z to 1600 m/z, at a resolution of 60,000. MS/MS in the ion trap was triggered for ions above 2000 with a maximum injection time of 10 ms for the 20 most intense precursor ions in RapidScan and a lockmass of 445.120024. Collision-induced dissociation (CID) fragmentation was performed at a collision energy of 35% and 0.25 activation Q.
Label-free protein identification and quantification were performed using MaxQuant version 1.4.1.2 59 with the following parameters: stable modification carbamidomethyl (C); variable modifications oxidation (M), acetylation (protein N terminus), and trypsin as enzyme with 2 missed cleavages. Search was conducted using a combined FASTA database of Serratia marcescens Db11 and the Uniprot Homo sapiens database (downloaded 1 May 2013), including common contaminants. Mass accuracy was set to 4.5 ppm for precursor ions and 0.5 Da for ion trap MS/MS data. Identifications were filtered at a 1% false-discovery rate (FDR) at the protein and peptide level, accepting a minimum peptide length of 7 amino acids. Quantification of identified proteins referred to razor and unique peptides, and required a minimum ratio count of 2. Normalized ratios were extracted for each protein and were used for downstream analyses.
In competition proteomics of bacterially intoxicated C. albicans. Isobaric labelling of peptides was performed using six-plex tandem mass tag (TMT) reagents (Thermo-Fisher Scientific). TMT reagents (0.8 mg) were dissolved in 40 μ l of acetonitrile and 20 μ l was added to six biological replicates of lyophilized peptide samples, previously dissolved in 50 μ l of 50 mM triethylammonium bicarbonate, pH 8.0. The individual samples of the strains were labelled as follows for all six replicates: WT, 126; Δ tssE, 127; Δ tfe1, 128; Δ tfe2, 129; Δ tfe1Δ tfe2, 130. After labelling, the reaction was quenched by addition of 4 μ l of 5% hydroxylamine after 1 hour incubation at room temperature. Individual samples were tested for labelling efficiency ( > 95%) before the labelled peptides were combined, acidified with 0.1% TFA and concentrated using C18 SPE on Sep-Pak cartridges (Waters). Equal loading of all five conditions was confirmed by the majority of peptide intensities not changing before normalization.
TMT-labelled peptides were subjected to hydrophilic Strong Anion Exchange (hSAX) fractionation. 60 Labelled peptides were solubilized in 20 mM Tris-HCl, pH 10.0) and separated on a Dionex RFIC IonPac AS24 column (IonPac series, 2 × 250 mm, 2,000 Å pore size; Thermo-Fisher Scientific). Using a DGP-3600BM pump system equipped with a SRD-3600 degasser (Thermo-Fisher Scientific) a 30 min gradient length from 8% to 80% of 1 M NaCl in 20 mM Tris-HCl, pH 10 (flow rate of 0.25 ml min −1 ), separated the peptide mixtures into a total of 34 fractions. The 34 fractions were merged into 9 samples, acidified with 1 %TFA (pH 2), desalted via C18 Macro SpinColumns (Harvard Apparatus), dried under vacuum centrifugation and resuspended in 2% ACN/0.1% TFA for LC-MS/MS analysis.
Peptide samples were separated on an Ultimate 3000 RSLC system with a C18 PepMap, serving as a trapping column (2 cm × 100 µ m ID, PepMap C18, 5 µ m particles, 100 Å pore size) followed by a 50 cm EASY-Spray column with a linear gradient consisting of (2.4-28% ACN, 0.1% FA) over 150 min at 300 nl min −1 . Mass spectrometric identification and quantification was performed on an Orbitrap Fusion Tribrid mass spectrometer (Thermo-Fisher Scientific) operated in data dependent, positive ion mode. FullScan spectra were acquired in a range from 400 m/z to 1,500 m/z, at a resolution of 120,000, with an automated gain control (AGC) of 300,000 ions and a maximum injection time of 50 ms. The 12 most intense precursor ions were isolated with a quadrupole mass filter width of 1.6 m/z and CID fragmentation was performed in one-step collision energy of 32% and 0.25 activation Q. Detection of MS/MS fragments was acquired in the linear ion trap in a rapid mode with an AGC target of 10,000 ions and a maximum injection time of 40 ms. Quantitative analysis of TMT-tagged peptides was performed using FTMS3 acquisition in the Orbitrap mass analyser operated at 60,000 resolution, with an AGC target of 100,000 ions and maximum injection time of 120 ms. Higher-energy C-trap dissociation (HCD fragmentation) on MS/MS fragments was performed in one-step collision energy of 55% to ensure maximal TMT reporter ion yield and synchronous-precursor-selection (SPS) was enabled to include 10 MS/MS fragment ions in the FTMS3 scan.
Protein identification and quantification were performed using MaxQuant version 1.5.1.7 59 with the following parameters: stable modification carbamidomethyl (C); variable modifications oxidation (M), acetylation (protein N terminus), deamidation (NQ), hydroxyproline (P), quantification labels with six-plex TMT on N-terminal or lysine with a reporter mass tolerance of 0.01 Da and trypsin as enzyme with 2 missed cleavages. Search was conducted using a combined FASTA database of Serratia marcescens Db11 and the Candida albicans SC5314 (assembly 22) database 61 (downloaded from www.candidagenome.org on 1 September 2015), including common contaminants. Mass accuracy was set to 4.5 ppm for precursor ions and 0.5 Da for ion trap MS/MS data. Identifications were filtered at a 1% FDR at the protein and peptide level, accepting a minimum peptide length of 7 amino acids. Quantification of identified proteins referred to razor and unique peptides, and required a minimum ratio count of 2. Normalized ratios were extracted for each protein/condition and were used for downstream analyses.
Mass spectrometry data analysis. Data was further analysed using the Perseus software package 62 . Pairwise comparisons were made using unpaired Student's t-tests (P < 0.05, two-sided). Multiple samples were analysed using ANOVA at P < 0.05 (multiple sample test). Perseus was also used for heat maps and clustering (Euclidean, 10 clusters) of ANOVA-positive proteins. For the S. marcescens cellular proteome, proteins were identified as differentially abundant when at least two unique peptides were identified, intensities were detected in a minimum of two out of the six biological replicates, and average LFQ intensities were altered more than 1.4-fold (|log 2 | > 0.5, P < 0.05). For the bacterially intoxicated C. albicans proteome, modulated proteins had significant ANOVA score (P < 0.05) and strong effector-specific changes were identified by pairwise comparison (fold change > 1.3, P < 0.05). Gene Ontology (GO) term analysis was carried out using the GO Term Finder Tool applying standard settings available at Candida Genome Database (CGD) 63 (http://www.candidagenome.org/). This version of GO Term Finder uses a hypergeometric distribution with Multiple Hypothesis Correction to calculate P values.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Data availability.
Raw mass spectrometry data that support the findings of this study have been deposited to the ProteomeXchange Consortium via the PRIDE 64 partner repository with the dataset identifier PXD006916. All other data supporting the findings of this study are available within the paper and its Supplementary Information. Corresponding author(s):
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